Q32 Bio Inc.QTTBNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-24.18M
↑ 54% vs avg
Percentile
P56
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-52.10M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-24.18M | +64.3% |
| 2024 | $-67.79M | -262.9% |
| 2023 | $-18.68M | -39.0% |
| 2022 | $-13.44M | +88.0% |
| 2021 | $-112.15M | -14.4% |
| 2020 | $-98.06M | +13.4% |
| 2019 | $-113.19M | -67.7% |
| 2018 | $-67.50M | -1593.1% |
| 2017 | $4.52M | +143.2% |
| 2016 | $-10.47M | - |